Dr Christopher Chen studied pre-clinical medicine at Fitzwilliam College, Cambridge University, where he majored in Physiology & Psychology. His clinical training was at the University of Oxford where he where he was a Research Fellow jointly with the Institute of Neurology, London. He is currently an Associate Professor at the Department of Pharmacology, National University of Singapore and Director of the Memory Aging and Cognition Centre, National University Health System. Since returning to Singapore in 1995, Dr Chen has developed a comprehensive multi-disciplinary dementia programme and encouraged collaborative research in the Asia-Pacific region and beyond. His current focus is on developing a regional network for innovative trials into conditions prevalent and pertinent to Asia. In addition, he has developed a Trials Unit focusing on stroke and dementia with wide international collaborations. His major research and clinical interests are in neurochemistry, molecular biology and treatment of stroke and dementia. He is currently the Principal Investigator of several investigator initiated trials, as well as cohort studies investigating the natural history, risk factors and biomarkers and treatments to prevent cognitive impairment and dementia due to cerebrovascular disease and neurodegeneration.